Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavannah Resources Regulatory News (SAV)

Share Price Information for Savannah Resources (SAV)

Share Price is delayed by 15 minutes
Get Live Data
7.10    0.20 (2.90%)
Bid:
7.00
Ask:
7.20
Spread: 0.20 (2.857%)
Market Cap: £182.86m
SAV Live PriceLast checked at - London Stock Exchange

Intraday Savannah Resources Share Chart

Issue and Allotment of Ordinary Shares

24 Sep 2014 09:32

RNS Number : 4740S
Savannah Resources PLC
24 September 2014
 



 

Savannah Resources Plc / Index: AIM / Epic: SAV / Sector: Mining

 

24 September 2014

Savannah Resources Plc

Issue and Allotment of Ordinary Shares

 

On 10 April 2014, Savannah Resources Plc (AIM:SAV) (the "Company") announced to the market a share purchase and convertible securities deed dated 10 April 2014 (the "Agreement"). Pursuant to the Agreement, on about 10 April 2014, the Company issued a convertible security with the nominal value of US$400,000 to Bergen Global Opportunity Fund, LP. The Company announces that on 23 September 2014 it issued 6,874,833 ordinary shares in a conversion of the convertible security in full. The Company has also issued, on 23 September 2014, 5,209,056 ordinary shares pursuant to the most recent monthly tranche draw down of US$303,080 under the Agreement (together, the "Relevant Shares"). Application has therefore been made for the Relevant Shares to be admitted to trading on AIM with admission expected to take place on 29 September 2014. The Relevant Shares will rank pari passu in all respects with all existing ordinary shares in the Company.

 

Following admission of the Relevant Shares, the Company's enlarged issued share capital will comprise 179,634,269 ordinary shares with voting rights. This figure of 179,634,269 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Disclosure and Transparency Rules.

 

**ENDS**

For further information please visit www.savannahresources.com or contact:

 

 

David Archer

Savannah Resources plc

Tel: +44 20 7389 5019

James Biddle (Nominated Adviser)

Charlie Cryer (Corporate Broker)

RFC Ambrian Limited

Tel: +44 20 3440 6800

Felicity Edwards/ Charlotte Heap

St Brides Media & Finance Ltd

Tel: +44 20 7236 1177

 

Notes

Savannah Resources Plc (AIM: SAV) is a growth oriented, multi-commodity, exploration and development company. It has an 80% shareholding in Matilda Minerals Limitada which operates the Jangamo exploration project in a world class mineral sands province in Mozambique which borders Rio Tinto's Mutamba deposit, one of two major deposits Rio Tinto has defined in Mozambique, which collectively have an exploration target of 7-12Bn tonnes at 3-4.5% THM1 (published in 2008).

 

Savannah has interests in two copper projects in the highly prospective Semail Ophiolite Belt in Oman. The projects, which have an Indicated and Inferred Mineral Resource of 1.7Mt @ 2.2% copper and high grade intercepts of up to 56.35m at 6.21% Cu, provide Savannah with an excellent opportunity to potentially evolve into a mid-tier copper producer in a relatively short time frame. Together with its Omani partners, Savannah aims to outline further mineral resources to provide the critical mass for a central operating plant to develop the deposits.

 

In addition, Savannah owns a 21.1% strategic shareholding in Alecto Minerals Plc which provides Savannah with exposure to both the highly prospective Kossanto Gold Project in the prolific Kenieba inlier in Mali and also to the Wayu Boda and Aysid Meketel gold / base metal projects in Ethiopia for which Alecto has a joint venture with Centamin Plc. Under this joint venture, Centamin Plc is committing up to US$14m in exploration funding to earn up to 70% of each project.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGIGDCBDDBGSS
Date   Source Headline
26th May 20267:00 amRNSExercise of Share Options
21st May 202612:20 pmRNSResult of Annual General Meeting
21st May 20267:00 amRNSAGM Statement
18th May 20267:00 amRNSTechnical work update and first capex purchase
11th May 20267:00 amRNSNotification of Major Shareholding
6th May 202612:30 pmRNSSecond temporary land access granted
1st May 20267:00 amRNSEquity Incentive Plan Awards
21st Apr 20267:00 amRNSInvestor Presentation
17th Apr 20267:00 amRNSHolding(s) in Company
16th Apr 20267:00 amRNSFinancial Results & Notice of AGM
7th Apr 20267:00 amRNSInvestor Presentation
23rd Mar 20267:00 amRNSProject Timetable Update
20th Mar 20267:00 amRNSHolding(s) in Company
26th Feb 20267:00 amRNSProject Update
21st Jan 20267:00 amRNSOfficial signing of the Portuguese State Grant
15th Jan 20267:00 amRNSProject and Market Update
9th Jan 202611:08 amRNSApproval of up to €110m Portuguese State Grant
23rd Dec 20257:00 amRNSChanges To Technical Team
23rd Dec 20257:00 amRNSChanges To Technical Team
19th Dec 20257:00 amRNSAcquisition of Aldeia Mining Lease - Update
19th Dec 20257:00 amRNSAcquisition of Aldeia Mining Lease - Update
12th Dec 20257:00 amRNSRESourceEU Action Plan – Update
4th Dec 20257:00 amRNSReconfirmation of Strategic Project Status
1st Dec 202511:30 amRNS-RSavannah CEO interviewed on Vox Markets
26th Nov 20257:00 amRNSOperational and Sector Update
25th Nov 20257:00 amRNSPurchase of shares by CEO
21st Nov 20257:00 amRNSNotification of Major Shareholding
19th Nov 20257:00 amRNSNotification of Major Shareholding
11th Nov 20253:40 pmRNSResult of RetailBook Offer
11th Nov 20257:00 amRNSInvestor Presentation
7th Nov 20257:40 amRNSInvestor Presentation via Investor Meet Company
7th Nov 20257:26 amRNSResult of Accelerated Bookbuild and Subscription
6th Nov 20255:37 pmRNSRetail Offer
6th Nov 20255:11 pmRNSProposed Fundraise
27th Oct 20257:00 amRNS-RMoU with local healthcare group
23rd Oct 20257:00 amRNSParticipation in trade delegations to Japan
21st Oct 20257:00 amRNSDismissal of Legal Claim
7th Oct 20257:01 amRNSBoard Changes
7th Oct 20257:00 amRNSNotification of Major Shareholding
29th Sep 20257:00 amRNSEquity Incentive Plan – Update
29th Sep 20257:00 amRNSChange of Registered Office
24th Sep 20257:00 amRNSInterim Results for six months ending 30 June 2025
23rd Sep 20258:55 amRNS-RInvestor Presentation
15th Sep 20257:00 amRNSBarroso Lithium Project - JORC Resource Update
4th Sep 20257:04 amRNSProject Update
21st Aug 20257:00 amRNSFinal Assays for Updated Resource Estimates
28th Jul 20257:00 amRNSEquity Incentive Plan
28th Jul 20257:00 amRNSInvestor Presentation
24th Jul 20257:00 amRNSAppointment of Project Finance Advisor
10th Jul 20257:02 amRNSInvestor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.